To test whether cancer cell antigen presentation was also enhanced, the peptide antigen transporter gene expression was evaluated, and the results indicated that Tap1, Tap2, Tapbp, B2m, H2D1, and H2K1 mRNA expression levels in cancer cells were increased after IR-780 treatment (Supplementary Figure 2). The gene discussed is TAP2; the disease is cancer.